The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord.
about
Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaAdenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysmsUsing caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional rolesA(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.Daily acute intermittent hypoxia elicits functional recovery of diaphragm and inspiratory intercostal muscle activity after acute cervical spinal injuryLocal glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injuryHow does adenosine control neuronal dysfunction and neurodegeneration?Receptor crosstalk: haloperidol treatment enhances A(2A) adenosine receptor functioning in a transfected cell model.Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.Critical contribution of adenosine A2A receptors in bone marrow-derived cells to white matter lesions induced by chronic cerebral hypoperfusion.Regulation of inositol 1,4,5-triphosphate receptor, type 1 (IP3R1) in hypoxic/reperfusion injury of white matter.Purinergic signaling in oligodendrocyte development and function.17β-estradiol attenuates neural cell apoptosis through inhibition of JNK phosphorylation in SCI rats and excitotoxicity induced by glutamate in vitro.
P2860
Q26851322-B0A411CB-AF65-4000-B50F-1A86F13DC09AQ30412759-E3AA3A3A-B18A-4240-977D-AB75F513F93EQ33971113-2675C726-8135-488D-9C0C-5383C01F57A2Q34002086-1991D19F-AC53-4BEF-AB39-DDDAD518151BQ34838463-382FEFFB-3227-4602-93B9-670AF448270AQ36473351-BAE00304-A2DD-4F13-A4C0-89569FE4ABDAQ37347604-D2FAC79A-8700-46A4-AD83-8799F27AFFCBQ38882782-9CD326B1-02C1-47B9-9235-DE42BAE77E82Q41948705-9A034637-C659-47EE-A4E6-52CF4637F6A1Q42107950-88BE9855-A941-4426-904B-EB9AE1A8A73BQ48288482-E1BBCCD3-99BD-4BDD-87D9-D49936119827Q48490680-CA7CEB10-8719-43D3-9724-EE852C38D30EQ49611755-ABA985FE-3053-4C6C-8910-2909D6BBA256Q50250298-8C23BBAB-4DCD-416E-9D8C-09D261FDD215
P2860
The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@en
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@nl
type
label
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@en
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@nl
prefLabel
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@en
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@nl
P2093
P50
P1433
P1476
The selective adenosine A2A re ...... ocytes in injured spinal cord.
@en
P2093
Alessia Melani
Emanuela Esposito
Felicita Pedata
P304
P356
10.1097/SHK.0B013E3181A20792
P577
2009-12-01T00:00:00Z